A novel neutralizing monoclonal antibody against cell-binding polypeptide of ricin.

Jian-Wei Guo,Bei-Fen Shen,Jian-Nan Feng,Ying-Xun Sun,Ming Yu,Mei-Ru Hu
DOI: https://doi.org/10.1089/hyb.2005.24.263
2005-01-01
Hybridoma
Abstract:One strain of neutralizing monoclonal antibody (MAb) against cell-binding polypeptide of ricin, named 3E1, was generated efficiently. The antibody recognized the linearity epitope of RTB located in a toxin structure domain characterized by Western blotting. The safe period of mice for intraperitoneal injection of 100 mu g of antibody was 20 min after intraperitoneal injection of 2 mu g of Ricin (10 times LD50). The neutralizing MAb we obtained could be developed into an immunotherapeutic agent to counteract the use of ricin as a terrorist or biological warfare weapon. It might be useful, as well, for antibody-based prophylaxis.
What problem does this paper attempt to address?